Skip to main content
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
    • UDDA Revision Series
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
    • UDDA Revision Series
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

August 27, 2019; 93 (9) Article

A large case-control study on vaccination as risk factor for multiple sclerosis

View ORCID ProfileAlexander Hapfelmeier, Christiane Gasperi, Ewan Donnachie, View ORCID ProfileBernhard Hemmer
First published July 30, 2019, DOI: https://doi.org/10.1212/WNL.0000000000008012
Alexander Hapfelmeier
From the Institute of Medical Informatics, Statistics and Epidemiology (A.H.), and Department of Neurology, Klinikum rechts der Isar (C.G., B.H.), Technical University of Munich; National Association of Statutory Health Insurance Physicians of Bavaria (E.D.); and Munich Cluster for Systems Neurology (SyNergy) (B.H.), Munich, Germany.
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alexander Hapfelmeier
Christiane Gasperi
From the Institute of Medical Informatics, Statistics and Epidemiology (A.H.), and Department of Neurology, Klinikum rechts der Isar (C.G., B.H.), Technical University of Munich; National Association of Statutory Health Insurance Physicians of Bavaria (E.D.); and Munich Cluster for Systems Neurology (SyNergy) (B.H.), Munich, Germany.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ewan Donnachie
From the Institute of Medical Informatics, Statistics and Epidemiology (A.H.), and Department of Neurology, Klinikum rechts der Isar (C.G., B.H.), Technical University of Munich; National Association of Statutory Health Insurance Physicians of Bavaria (E.D.); and Munich Cluster for Systems Neurology (SyNergy) (B.H.), Munich, Germany.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bernhard Hemmer
From the Institute of Medical Informatics, Statistics and Epidemiology (A.H.), and Department of Neurology, Klinikum rechts der Isar (C.G., B.H.), Technical University of Munich; National Association of Statutory Health Insurance Physicians of Bavaria (E.D.); and Munich Cluster for Systems Neurology (SyNergy) (B.H.), Munich, Germany.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Bernhard Hemmer
Full PDF
Short Form
Citation
A large case-control study on vaccination as risk factor for multiple sclerosis
Alexander Hapfelmeier, Christiane Gasperi, Ewan Donnachie, Bernhard Hemmer
Neurology Aug 2019, 93 (9) e908-e916; DOI: 10.1212/WNL.0000000000008012

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
623

Share

  • Article
  • Figures & Data
  • Info & Disclosures
  • CME Course
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Abstract

Objective To investigate the hypothesis that vaccination is a risk factor for multiple sclerosis (MS) by use of German ambulatory claims data in a case-control study.

Methods Using the ambulatory claims data of the Bavarian Association of Statutory Health Insurance Physicians covering 2005–2017, logistic regression models were used to assess the relation between MS (n = 12,262) and vaccinations in the 5 years before first diagnosis. Participants newly diagnosed with Crohn disease (n = 19,296) or psoriasis (n = 112,292) and participants with no history of these autoimmune diseases (n = 79,185) served as controls.

Results The odds of MS were lower in participants with a recorded vaccination (odds ratio [OR] 0.870, p < 0.001 vs participants without autoimmune disease; OR 0.919, p < 0.001 vs participants with Crohn disease; OR 0.973, p = 0.177 vs participants with psoriasis). Lower odds were most pronounced for vaccinations against influenza and tick-borne encephalitis. These effects were consistently observed for different time frames, control cohorts, and definitions of the MS cohort. Effect sizes increased toward the time of first diagnosis.

Conclusions Results of the present study do not reveal vaccination to be a risk factor for MS. On the contrary, they consistently suggest that vaccination is associated with a lower likelihood of being diagnosed with MS within the next 5 years. Whether this is a protective effect needs to be addressed by future studies.

Glossary

BASHIP=
Bavarian Association of Statutory Health Insurance Physicians;
CI=
confidence interval;
GOP=
Gebührenordnungspositionen;
HPV=
human papilloma virus;
ICD-10=
International Classification of Diseases–10;
MMR=
measles, mumps, and rubella;
MS=
multiple sclerosis;
OR=
odds ratio;
TBE=
tick-borne encephalitis;
VZV=
varicella-zoster virus

Footnotes

  • Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.

  • ↵* These authors contributed equally to this work.

  • Editorial, Page 377

  • Podcast: NPub.org/b4quxb

  • CME Course: NPub.org/cmelist

  • Received February 20, 2019.
  • Accepted in final form April 29, 2019.
  • © 2019 American Academy of Neurology
View Full Text

AAN Members

We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.

Google Safari Microsoft Edge Firefox

Click here to login

AAN Non-Member Subscribers

Click here to login

Purchase access

For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)

Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here 

Purchase
Individual access to articles is available through the Add to Cart option on the article page.  Access for 1 day (from the computer you are currently using) is US$ 39.00.  Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means.  The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use.  Distributing copies (electronic or otherwise) of the article is not allowed.

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Abstract
    • Glossary
    • Methods
    • Results
    • Discussion
    • Study funding
    • Disclosure
    • Appendix Authors
    • Footnotes
    • References
  • Figures & Data
  • Info & Disclosures
  • CME Course

More Online

CME Course

Association of Mediterranean-DASH Intervention for Neurodegenerative Delay and Mediterranean Diets With Alzheimer Disease Pathology

Dr. Babak Hooshmand and Dr. David Smith

► Watch

Related Articles

  • VaccinationNot a trigger for MS
  • What's happening in Neurology®

Topics Discussed

  • Multiple sclerosis
  • Case control studies
  • Risk factors in epidemiology

Alert Me

  • Alert me when eletters are published

Recommended articles

  • Special Article
    Practice guideline update summary: Vaccine-preventable infections and immunization in multiple sclerosis
    Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology
    Mauricio F. Farez, Jorge Correale, Melissa J. Armstrong et al.
    Neurology, August 28, 2019
  • Editorial
    Vaccination
    Not a trigger for MS
    E. Ann Yeh, Jennifer Graves et al.
    Neurology, July 30, 2019
  • Research
    Uptake and Attitudes About Immunizations in People With Multiple Sclerosis
    Ruth Ann Marrie, Leanne Kosowan, Gary R. Cutter et al.
    Neurology: Clinical Practice, April 22, 2021
  • Article
    Systematic Assessment of Medical Diagnoses Preceding the First Diagnosis of Multiple Sclerosis
    Christiane Gasperi, Alexander Hapfelmeier, Tanja Daltrozzo et al.
    Neurology, April 26, 2021
Neurology: 101 (13)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise